China's 111 Inc Q1 revenue falls 33% on business model transition
China's 111 Inc Q1 revenue falls 33% on business model transition
Overview
China healthcare platform's Q1 revenue fell 33% yr/yr amid asset-light business model transition
Adjusted EPS and net income remained negative, with losses widening from a year earlier
Company's promotional products revenue rose 70% and marketplace service revenue grew 25% yr/yr
Outlook
Company expects to continue integrating AI-enabled capabilities to improve operational efficiency
111 Inc aims to expand margins and lift profitability through a lean, intelligent operating model
Company plans to pursue scalable growth by expanding partnerships and promoted pharmaceutical products
Result Drivers
BUSINESS MODEL TRANSITION - Revenue declined 33% yr/yr as co continued its shift to an asset-light, platform-oriented model, including divesting underperforming subsidiaries and expanding warehouse partnerships
PROMOTIONAL PRODUCTS GROWTH - Revenue from promotional products rose 70% yr/yr, with gross profit up 75%, driven by expanded partnerships and increased sales of flagship products such as Cravit
COST MANAGEMENT - Fulfillment expenses fell 35% yr/yr and improved as a percentage of revenue, reflecting network optimization and disciplined cost controls
Company press release: ID:nPn60Ct0ha
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q1 Revenue |
| RMB 2.40 bln |
|
Q1 Adjusted Net Income |
| -RMB 25.70 mln |
|
Q1 Net Income |
| -RMB 26.80 mln |
|
Q1 Adjusted Income From Operations |
| -RMB 18.80 mln |
|
Q1 Income From Operations |
| -RMB 20 mln |
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)